| HOME >> BIOLOGY >> TECHNOLOGY |
Recently, at Arizona State University's Biodesign Institute, N.J. Tao and collaborators have found a way to make a key electrical component on a phenomenally tiny scale. Their single-molecule diode is described in this week's online edition of Nature Chemistry.
In the electronics world, diodes are a versatile and ubiquitous component. Appearing in many shapes and sizes, they are used in an endless array of devices and are essential ingredients for the semiconductor industry. Making components including diodes smaller, cheaper, faster and more efficient has been the holy grail of an exploding electronics field, now probing the nanoscale realm.
Smaller size means cheaper cost and better performance for electronic devices. The first generation computer CPU used a few thousand transistors, Tao says noting the steep advance of silicon technology. "Now even simple, cheap computers use millions of transistors on a single chip."
But lately, the task of miniaturization has gotten much harder, and the famous dictum known as Moore's lawwhich states that the number of silicon-based transistors on a chip doubles every 18-24 monthswill eventually reach its physical limits. "Transistor size is reaching a few tens of nanometers, only about 20 times larger than a molecule," Tao says. "That's one of the reasons people are excited about this idea of molecular electronics."
Diodes are critical components for a broad array of applications, from power conversion equipment, to radios, logic gates, photodetectors and light-emitting devices. In each case, diodes are components that allow current to flow in one direction around an electrical circuit but not the other. For a molecule to perform this feat, Tao explains, it must be physically asymmetric, with one end capable of forming a covalent bond with the negatively charged anode and the other with the positive cathode terminal.
The new study compares a symmetric molecule wit
'/>"/>
| Contact: Joe Caspermeyer joseph.caspermeyer@asu.edu 480-727-0369 Arizona State University Source:Eurekalert |
Related biology technology :
1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
5. New technique producing small things in large quantities
6. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
7. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
8. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
9. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
10. Government Expands Trial With IMVAMUNE(R) Smallpox Vaccine in Persons With Atopic Dermatitis/Eczema
11. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |